Imaging of brain activity and behavioral disorders.
Recent advances in brain imaging permit metabolic variables to be measured in psychiatric patients. These include regional cerebral blood flow, oxygen utilization, oxygen extraction and glucose utilization--all measures which reflect CNS energy utilization. The quantitative relationships between these metabolic parameters, neuronal activity, and higher cortical function are poorly understood. In evaluating the results of imaging studies, it is important to establish whether the reported changes correlate with episodic symptomatology or with a chronic disease process. Affective disorders exemplify conditions which are episodic, progress rapidly and respond to medication, making it difficult to identify consistent patterns of metabolic change. Thus unipolar subgroups have been described with both left and right metabolic predominance. On the other hand, imaging studies in dementia have consistently shown decreased glucose utilization, and more particularly poor verbal performance may go with reduced glucose uptake in the left temporal/parietal area. Although neuro-imaging studies are still at an early stage, the additional capacity to measure regional receptor distribution and kinetics using ligands tagged with positron emitters will open up new dimensions in the study of psycho-pathophysiology.
D000544:Alzheimer Disease / Q000503:physiopathology; D001786:Blood Glucose / Q000378:metabolism; D001810:Blood Volume; D001921:Brain / Q000503:physiopathology*; D002560:Cerebrovascular Circulation; D002908:Chronic Disease; D004734:Energy Metabolism; D006801:Humans; D001523:Mental Disorders / Q000503:physiopathology*; D019964:Mood Disorders / Q000503:physiopathology; D009410:Nerve Degeneration; D009483:Neuropsychological Tests; D010101:Oxygen Consumption; D009435:Synaptic Transmission
D001786:Blood Glucose